EDX Medical confirms date for 2025 Annual General Meeting

EDX Medical Group Plc (AQSE: EDX), which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, heart disease and infectious diseases, has announced that its annual general meeting (AGM) will be held at the Marcus Beck Library, 3rd Floor, Royal School of Medicine, 1 Wimpole Street, Westminster, London, W1G 0AE on 29 September 2025 at 2:00 p.m.

The annual report and financial statements for the year ended 31 March 2025, Notice of AGM and Form of Proxy will be posted today, 1 September 2025, to eligible shareholders. Electronic copies will be shortly available on the Company’s website at: https://edxmedical.co.uk/documents/

Share on:

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
EDX Medical Group plc

Latest Company News

EDX Medical begins second phase of Scottish Prostate Cancer Testing Initiative

August 27, 2026

EDX Medical has begun the second phase of the Scottish Prostate Cancer Initiative, with 12,500 more men set to receive free PSA testing as part of a programme aiming to test 25,000 men across Scotland.

EDX Medical raises £2.7m to expand employee health screening service

August 24, 2026

EDX Medical has raised approximately £2.7m through a share subscription to support the expansion of its employee health screening service, as discussions progress with several major UK employers.

EDX Medical targets corporate health market with new screening service

August 19, 2026

EDX Medical is preparing to launch a corporate health screening service covering 14,000 employees, with testing expected to begin in Q4 2026.

EDX Medical positioned in growing prostate screening push

August 11, 2026

EDX Medical is positioned in the growing prostate screening debate as demand builds for more accurate, less invasive diagnostic testing.

EDX Medical Group deploys rapid pneumonia test at Addenbrooke’s ICU

August 3, 2026

EDX Medical Group has said its rapid pneumonia test is now in NHS clinical practice and has benefited patients at Addenbrooke's Hospital.

Professor Sir Chris Evans outlines EDX Medical’s new workplace health screening service

July 24, 2026

EDX Medical’s Chief Scientific Officer discusses the service’s on-site testing model, competitive advantages, employer demand and potential to generate more than £2 million this financial year.

EDX Medical confirms date for 2025 Annual General Meeting

We’ll keep you in the loop!

Latest Company News

Search

Follow us on Social Media: